Neuronal regulation of aortic valve cusps

Current Vascular Pharmacology

Volumn 7, Issue 1, 2009, Pages 40-46

  El Hamamsy, Ismail ^a   Yacoub, Magdi H ^a   Chester, Adrian H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Aortic valve; Calcification; Mechanical properties; Nerves

Indexed keywords

AORTA VALVE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART CYCLE; HEART INNERVATION; HEMODYNAMICS; MICROSCOPY; NERVE; NONHUMAN; REVIEW; ANIMAL; CALCINOSIS; DRUG DELIVERY SYSTEM; HUMAN; INNERVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; VALVULAR HEART DISEASE;

ANIMALS; AORTIC VALVE; CALCINOSIS; DRUG DELIVERY SYSTEMS; HEART VALVE DISEASES; HEMODYNAMICS; HUMANS;

EID: 61549142440     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016109787354088     Document Type: Review

References (57)

1. Woollard HH. The Innervation of the Heart. J Anat 1926; 60(Pt 4): 345-73.
2. Voloshchenko AA. Afferent innervation of atrioventricular valve. Fed Proc Transl Suppl 1965; 24: 571-4.
3. Williams TH. Mitral and Tricuspid Valve Innervation. Br Heart J 1964; 26: 105-15.
4. Steele PA, Gibbins IL, Morris JL. Projections of intrinsic cardiac neurons to different targets in the guinea-pig heart. J Auton Nerv Syst 1996; 56: 191-200.
5. Marron K, Yacoub MH, Polak JM, Sheppard MN, Fagan D, Whitehead BF, et al. Innervation of human atrioventricular and arterial valves. Circulation 1996; 94: 368-75.
6. Kawano H, Shirai T, Kawano Y, Okada R. Morphological study of vagal innervation in human semilunar valves using a histochemical method. Jpn Circ J 1996; 60: 62-6.
7. Kawano H, Kawai S, Shirai T, Okada R. Morphological study on vagal innervation in human atrioventricular valves using histochemical method. Jpn Circ J 1993; 57: 753-9.
8. De Biasi S, Vitellaro-Zuccarello L. Intrinsic innervation of porcine semilunar heart valves. Anat Embryol (Berl) 1982; 165: 71-9.
9. Zukowska Z, Pons J, Lee EW, Li L. Neuropeptide Y: A new mediator linking sympathetic nerves, blood vessels and immune system? Can J Physiol Pharmacol 2003; 81: 89-94.
10. Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 1993; 73: 229-308.
11. Hoover DB, Chang Y, Hancock JC, Zhang L. Actions of tachykinins within the heart and their relevance to cardiovascular disease. Jpn J Pharmacol 2000; 84: 367-73.
12. Fenoglio JJ, Jr., Tuan Duc P, Wit AL, Bassett AL, Wagner BM. Canine mitral complex. Ultrastructure and electromechanical properties. Circ Res 1972; 31: 417-30.
13. Ahmed A, Johansson O, Folan-Curran J. Distribution of PGP 9.5, TH, NPY, SP and CGRP immunoreactive nerves in the rat and guinea pig atrioventricular valves and chordae tendineae. J Anat 1997; 191 (Pt 4): 547-60.
14. Williams TH, Folan JC, Jew JY, Wang YF. Variations in atrioventricular valve innervation in four species of mammals. Am J Anat 1990; 187: 193-200.
15. Jew JY, Williams TH. Innervation of the mitral valve is strikingly depleted with age. Anat Rec 1999; 255: 252-60.
16. Folan-Curran J, Wang YF, Jew JY, Williams TH. The terminal innervation patterns in young and old guinea pig heart valves: A quantitative analysis using acetylcholinesterase staining. Exp Gerontol 1994; 29: 543-52.
17. Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF. Mitral valve prolapse syndrome: the effect of adrenergic stimulation. J Am Coll Cardiol 1983; 2: 638-44.
18. Kawano T, Oki T, Uchida T, Iuchi A, Ogawa S, Hayashi M, et al. Innervation of the mitral valve in normal and prolapsed mitral valves. J Cardiol Suppl; 21: 43-54, discussion 5-6.
19. Coghlan HC, Phares P, Cowley M, Copley D, James TN. Dysautonomia in mitral valve prolapse. Am J Med 1979; 67: 236-44.
20. Styres KS. The phenomenon of dysautonomia and mitral valve prolapse. J Am Acad Nurse Pract 1994; 6: 11-5.
21. Bell DS, Acton RT. Increased prevalence of mitral valve prolapse in IDDM. Diabetes Care 1996; 19: 672.
22. Imataka K, Yamaoki K, Seki A, Takayama Y, Fujii J. Peculiar mitral valve and papillary muscle lesions induced by vagus manipulations in rabbits. An experimental model for nonrheumatic mitral regurgitation. Jpn Heart J 1986; 27: 377-86.
23. Imataka K, Kitahara Y, Naito S, Fujii J. A new model for infective endocarditis of the mitral valve in rabbits. Am Heart J 1993; 125(5 Pt 1): 1353-7.
24. Roy A, Brand NJ, Yacoub MH. Molecular characterization of interstitial cells isolated from human heart valves. J Heart Valve Dis 2000; 9: 459-64; discussion 64-5.
25. Taylor PM, Allen SP, Yacoub MH. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. J Heart Valve Dis 2000; 9: 150-8.
26. Williams TH, Jew JY. Is the mitral valve passive flap theory over-stated? An active valve is hypothesized. Med Hypotheses 2004; 62: 605-11.
27. Bowen IM, Marr CM, Chester AH, Wheeler-Jones CP, Elliott J. In vitro contraction of the equine aortic valve. J Heart Valve Dis 2004; 13: 593-9.
28. Chester AH, Misfeld M, Yacoub MH. Receptor-mediated contraction of aortic valve leaflets. J Heart Valve Dis 2000; 9: 250-4; discussion 4-5.
29. Chester AH, Misfeld M, Sievers HH, Yacoub MH. Influence of 5-hydroxytryptamine on aortic valve competence in vitro. J Heart Valve Dis 2001; 106: 822-5; discussion 5-6.
30. Pompilio G, Rossoni G, Sala A, Polvani GL, Berti F, Dainese L, et al. Endothelial-dependent dynamic and antithrombotic properties of porcine aortic and pulmonary valves. Ann Thorac Surg 1998; 65: 986-92.
31. Ohashi M, Satoh K, Itoh T. Acetylcholine-induced membrane potential changes in endothelial cells of rabbit aortic valve. Br J Pharmacol 1999; 126: 19-26.
32. Ku DD, Nelson JM, Caulfield JB, Winn MJ. Release of endothelium-derived relaxing factors from canine cardiac valves. J Cardiovasc Pharmacol 1990; 16: 212-8.
33. Siney L, Lewis MJ. Nitric oxide release from porcine mitral valves. Cardiovasc Res 1993; 27: 1657-61.
34. Chester AHK JC, Sarathchandra P, Yacoub MH. Inhibition of neuronal derived nitric oxide unmasks contractile responses of aortic valve cusps. Circulation 2005; 112: SII-84.
35. Chester AHK JC, Sarathchandra P, Yacoub MH. Localisation and function of nerves in the porcine aortic root. J Mol Cell Cardiol 2008.
36. Lansac E, Lim HS, Shomura Y, Lim KH, Goetz W, Rice NT, et al. Aortic and pulmonary root: Are their dynamics similar? Eur J Cardiothorac Surg 2002; 21: 268-75.
37. Lansac E, Lim HS, Shomura Y, Lim KH, Rice NT, Goetz W, et al. A four-dimensional study of the aortic root dynamics. Eur J Cardiothorac Surg 2002; 22: 497-503.
38. Pang DC, Choo SJ, Luo HH, Shomura YU, Daniel S, Nikolic S, et al. Significant increase of aortic root volume and commissural area occurs prior to aortic valve opening. J Heart Valve Dis 2000; 9: 9-15.
39. Lansac E, Lim HS, Shomura Y, Lim KH, Rice NT, Goetz WA, et al. Aortic root dynamics are asymmetric. J Heart Valve Dis 2005; 14: 400-7.
40. Imataka K, Takahashi N, Seki A, Fujii J. Experimental production of papillary muscle and mitral valve lesions by vagal manipulations in rabbits. Jpn Circ J 1982; 46: 362-8.
41. Hafizi S, Taylor PM, Chester AH, Allen SP, Yacoub MH. Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents. J Heart Valve Dis 2000; 9: 454-8.
42. Xu J, Jian B, Chu R, Lu Z, Li Q, Dunlop J, et al. Serotonin Mechanisms in Heart Valve Disease II: The 5-HT2 Receptor and Its Signaling Pathway in Aortic Valve Interstitial Cells. Am J Pathol 2002; 161: 2209-18.
43. Roy A, Brand NJ, Yacoub MH. Expression of 5-hydroxytryptamine receptor subtype messenger RNA in interstitial cells from human heart valves. J Heart Valve Dis 2000; 9: 256-60; discussion 60-1.
44. Rajamannan NM, Caplice N, Anthikad F, Sebo TJ, Orszulak TA, Edwards WD, et al. Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects. J Heart Valve Dis 2001; 10: 827-31.
45. Antonini A, Poewe W. Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease. Lancet Neurol 2007; 6: 826-9.
46. Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease. N Engl J Med 2007; 356: 39-46.
47. Rothman RB, Baumann MH, Savage JE, Rauser L, McBride A, Hufeisen SJ, et al. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 2000; 102: 2836-41.
48. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005; 434: 514-20.
49. Osman L, Chester AH, Sarathchandra P, Latif N, Meng W, Taylor PM, et al. A novel role of the sympatho-adrenergic system in regulating valve calcification. Circulation 2007; 116: I282-7.
50. Osman L, Chester AH, Amrani M, Yacoub MH, Smolenski RT. A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin. Circulation 2006; 114: I566-72.
51. Osman L, Yacoub MH, Latif N, Amrani M, Chester AH. Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation 2006; 114: I547-52.
52. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 2007; 171: 1407-18.
53. Pasco JA, Henry MJ, Nicholson GC, Schneider HG, Kotowicz MA. Beta-blockers reduce bone resorption marker in early postmenopausal women. Ann Hum Biol 2005; 32: 738-45.
54. Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, et al. beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res 2005; 20: 613-8.
55. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 2007; 356: 29-38.
56. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997; 337: 581-8.
57. Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, et al. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 1995; 92: 790-5.